-
Clozapine Workflows for Schizophrenia Research
2026-08-15
Build reproducible Clozapine experiments that connect multi-receptor pharmacology with prefrontal ERK1/2 signaling and emerging GABRE biology. This practical guide covers cell-based assays, magnetic-stimulation comparisons, hepatotoxicity studies, dosing logic, and troubleshooting.
-
Amikacin (BAY416651) Resistance Workflows
2026-08-14
Build reproducible amikacin assays that connect bacterial protein synthesis inhibition with genotype, plasmid mobility, and resistance phenotyping. This workflow is especially useful for carbapenem-resistant Enterobacter cloacae and Klebsiella pneumoniae research, while keeping product handling and interpretation constraints explicit.
-
Lumiracoxib: A Time-Resolved COX-2 Research Guide
2026-08-14
Lumiracoxib is a selective COX-2 inhibitor that can do more than suppress inflammatory readouts: it can help researchers determine when COX-2-derived prostaglandins protect injured tissue or reshape repair. This guide translates venom-induced muscle injury findings into rigorous, time-aware assay design and interpretation.
-
Sodium Ascorbate: Cancer Assay Workflow Guide
2026-08-13
Learn how to deploy Sodium Ascorbate as a controlled oxidative-stress perturbation in glioblastoma and broader cancer cell assays. This guide combines formulation safeguards, ROS and viability workflows, reference-study insights, and practical troubleshooting for reproducible preclinical experiments.
-
Pifithrin-α: A Practical p53 Inhibitor Workflow
2026-08-13
Pifithrin-α (PFTα) is a practical chemical probe for separating p53-dependent apoptosis, ferroptosis, and radiation-associated growth arrest in cell models. This workflow translates recent deltamethrin neurotoxicity findings into assay design, controls, dosing logic, and troubleshooting strategies.
-
Phosphatase Inhibitor Cocktail (2 Tubes, 100X)
2026-08-12
Phosphatase Inhibitor Cocktail (SKU K1015) helps limit endogenous phosphatase activity during protein extraction and downstream phosphorylation analyses. It is intended for research workflows such as immunoblotting, immunoprecipitation, kinase assays, and mass spectrometry, but it should not be treated as a diagnostic, medical, or unvalidated live-cell reagent.
-
Halazone and Sodium Current Inactivation in Frog Nerves
2026-08-12
The 1986 frog nerve-fiber study showed that Halazone and hypochlorous acid strongly disrupt sodium-current inactivation, while other oxidants produce distinct voltage-dependent shifts. Its comparative reagent design challenged a methionine-centered explanation and pointed instead toward chemically modifiable membrane components, potentially including lipids.
-
ECL Chemiluminescent Substrate Detection Kit for RCC
2026-08-11
The ECL Chemiluminescent Substrate Detection Kit connects HRP-based Western blot chemiluminescence detection with mechanistic studies of Syringin and Sunitinib response in renal cell carcinoma. Learn how to design, interpret, and quality-control ECL assays so pathway evidence is stronger and more reproducible.
-
Streptavidin – Cy5 for Breast Cancer Assays
2026-08-11
Learn how a far-red fluorescent streptavidin conjugate can convert biotinylated antibodies, probes, and proteins into measurable signals across immunofluorescence, immunohistochemistry, and flow cytometry. This practical guide connects assay design and troubleshooting to recent findings on USP42-driven breast cancer progression.
-
ABT-888 (Veliparib): PARP1/2 Research Guide
2026-08-10
ABT-888, also called Veliparib, is a PARP1 and PARP2 inhibitor used to study DNA repair inhibition and cancer-treatment sensitization. Preclinical data support chemotherapy and radiation sensitizer applications, but acute-leukemia calicheamicin data show that PARP inhibition is not universally effective across DNA-damaging therapies.
-
CK2 and ERK8 Inhibitor: Condensate-Aware Guide
2026-08-09
Explore how the CK2 and ERK8 inhibitor B7464 can support kinase-centered studies of phosphorylation and biomolecular condensation. This evidence-aware guide distinguishes validated SARS-CoV-2 nucleocapsid LLPS findings from hypothesis-generating applications for a small molecule inhibitor.
-
Viperin Targets Coronavirus nsp8 to Block RNA Synthesis
2026-08-08
A 2026 study identifies a non-catalytic antiviral mechanism in which viperin binds coronavirus nsp8, disrupts replication-transcription complex assembly, and reduces RNA-dependent RNA polymerase activity. Using porcine deltacoronavirus as a model, the work separates this conserved protein-interaction mechanism from viperin-mediated ddhCTP production and suggests a broader framework for coronavirus antiviral drug development.
-
FGFR Signaling in Guinea Pig Penile Development
2026-08-07
This study identifies species-specific timing and expression of Shh, Fgf10, and Fgfr2 as major determinants of whether the developing penis forms an open urethral groove and when the prepuce develops. Its comparative imaging, gene-expression, and organ-culture experiments provide a framework for interpreting genital development beyond the mouse model while highlighting limits on direct translation to humans.
-
Direct Mouse Genotyping Kit Plus: Precision Genotyping Made
2026-08-07
The Direct Mouse Genotyping Kit Plus streamlines rapid DNA extraction and PCR from mouse tissue, eliminating the need for purification steps. This kit empowers researchers to accelerate mouse genotyping, transgene detection, and gene knockout validation with high-fidelity results—making it indispensable for modern colony management.
-
Integrating Transcriptomic and Functional Profiling for Card
2026-08-06
This study advances cardiovascular toxicology by combining transcriptomic and functional data from human iPSC-derived cardiomyocytes to more comprehensively identify and characterize environmental cardiotoxicants. The approach enables mechanistic interpretation and improved risk prioritization, offering researchers an adaptable, high-throughput platform for hazard screening.